2SchSu MP, Boehncke WH. Psoriasis. New Eng J Med,2005,352 (18) : 1899-1912.
3Holick MF. Medicalprogress: vitamin D deficiency. New Eng J Med,2007,357(3) :26-28.
4Ikeda U, Wakita D, Ohkurietal T, et al. lc~,25-dihydroxyvita- min D3 and all-trans retinoic acid synergistically inhibit the dif- ferentiation and expansion of Thl7 cells. Immunology Letters, 2010,134(1) :7-16.
5Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis : a hospital-based casecontrol study. Br J Dermatol,2007,157( 1 ) :68-73.
6Eckel RH, Grundy SM, Zimmet PZ, et al. The metabolic syn-drome. Lancet, 2005,365 ( 9468 ) : 1415-1428.
7Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol, 2013,68 (4) : 654- 662.
8Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metabol Clinics North America,2004,33(2) :351-375.
9Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epide- miology and pathophysiology. Current Opinion in Rheumatology, 2008,20(4) :416-422.
10Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based casecontrol study. Br J Dermatol,2007,157( 1 ) :68-73.
